TrialCardiovascular diabetology2023

Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trial.

Giuseppe Rosano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.